Protein Binding Assays Market – Global Industry Analysis and Forecast (2023-2029)

Global Protein Binding Assays Market size is expected to grow at a CAGR of 11% during the forecast period and the market size is expected to reach nearly USD 859.43Million by 2029.
Global Protein Binding Assays Market Overview
Protein binding assay is used to measure interactions between two molecules, such as protein binding another protein, a small molecule, or nucleic acid. The protein binding assay is gradually being accepted in the preclinical stages of drug discovery & development programs. According to U.S. FDA, 4 novel therapeutics and biologics were approved by the Center for Drug Evaluation and Research (CDER) in 2020 as compared to 48 new drugs approved in 2019. So, the surge in the number of drug candidates being screened and sanctioned annually drives the acceptance of protein binding assays.
Protein Binding Assays Market Snapshot
To know about the Research Methodology :- Request Free Sample Report

Drug discovery & development is cost-intensive and requires high capital investment, technological capabilities, and human resources. During the development stages, manufacturers suffer a considerable loss if a drug candidate fails.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.
Global Protein Binding Assays market Drivers and Restraints:
The protein binding assay is a widely used process for new drug development. The growth of the protein binding assays market is xx% increased by the development of various advanced technologies utilized for protein binding. The many pharmaceutical and biotechnology companies are concentrating on new drug developments that leading to a growth in drug discovery activities. Increasing focus on reduction of the costs being experienced on the drug discovery and their manufacturing is the major factor expected to propel the growth of the market. In situ protein-protein interaction assay is more sensitive method than other conventional, methods, which anticipated to boost execution of these assays in laboratories as an advanced method.

However, the Shortage of information and skills related to the application of protein binding assays is another factor restricting this market growth. Concerns regarding various complications associated with technology available, which is to be used in combination with these products is anticipated to hamper the growth of the market.

For instance, in (April 5, 2019) Calixar announces a collaborative research agreement with Thermo Fisher Scientific on multiple membrane proteins of high relevance to drug discovery.

The market is segmented into Technology, End user and Application. Based on the technology, Equilibrium dialysis market has largest share and dominating the protein binding assays market because of its simplicity, low costs, and high accuracy. North America accounted for the largest share in the protein binding assays market because of funds provided from public and private entities for drug discovery and development.

A number of conferences on pharma research such as, 2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry was scheduled on May 30-31, 2019 at Orlando also boost the regional growth. Asia Pacific region is anticipated to see highest growth for protein binding assays market because of initiatives undertaken by agencies to transform drug discovery & development programs and low cost of preclinical methods ,which helps to outsource the services to the region.

The objective of the report is to present a comprehensive analysis of the Global Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by Region.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by Region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Protein Binding Assays Market dynamics, structure by analyzing the market segments and project the Global Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.
Scope of the Global Protein Binding Assays Market: Inquire before buying



Global Protein Binding Assays Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US $ 413.95 Mn.


Forecast Period 2023 to 2029 CAGR:
11%
Market Size in 2029:
US $ 859.43 Mn.


 Segments Covered:
by Technology
Equilibrium dialysis
Ultrafiltration
Ultracentrifugation
Other technologies


by End User
Pharmaceutical & biotechnology companies
Contract research organizations (CROs)
Other end users (academic institutes and government organizations)



Protein Binding Assays Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Protein Binding Assays Market, Key Players are
1. Thermo Fisher Scientific (US)
2. Charles River
3. GE Healthcare (US)
4. Danaher (US)
5. Sovicell GMBH
6. Absorption Systems LLC
7. GE Healthcare
8. Eurofins Scientific
9. 3B Pharmaceuticals
10. Creative Biolabs
11. Evotec (Cyprotex)
12. Bioduro
13. Sartorius Stedim BioOutsource Limited
14. Bio-Rad Laboratories, Inc.
15. nanoComposix; Abzena Ltd
16. Abcam plc
17. GVK Biosciences Private Limited
18. Promega Corporation
19. Merck KGaA
20. Cyprotex
21. ADMEcell, Inc.
22. 3B Pharmaceuticals
23. Biotium
24. Beckman Coulter, Inc.
25. Sartorius Stedim BioOutsource Limited
26. Arrayit Corporation

Frequently Asked Questions:

1. Which region has the largest share in Global Protein Binding Assays Market?
Ans: Asia Pacific region held the highest share in 2022.

2. What is the growth rate of Global Protein Binding Assays Market?
Ans: The Global Protein Binding Assays Market is growing at a CAGR of 11% during forecasting period 2023-2029.

3. What is scope of the Global Protein Binding Assays Market report?
Ans: Global Protein Binding Assays Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Protein Binding Assays Market?
Ans: The important key players in the Global Market are – Thermo Fisher Scientific (US), Charles River, GE Healthcare (US), Danaher (US), Sovicell GMBH, Absorption Systems LLC, GE Healthcare, Eurofins Scientific, 3B Pharmaceuticals, Creative Biolabs, Evotec (Cyprotex), Bioduro, Sartorius Stedim BioOutsource Limited, Bio-Rad Laboratories, Inc., nanoComposix; Abzena Ltd, Abcam plc, GVK Biosciences Private Limited, Promega Corporation, Merck KGaA, Cyprotex, ADMEcell, Inc., 3B Pharmaceuticals, Biotium, Beckman Coulter, Inc., Sartorius Stedim BioOutsource Limited, Arrayit Corporation.

5. What is the study period of this Market?
Ans: The Global Market is studied from 2022 to 2029.